Biotech News

ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform

ProPhase Labs (PRPH)ProPhase Labs2026-06-25 13:46 ESTCompany update

PRPH (PRPH) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is prph.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

PRPHProPhase Labs2026-06-25 13:46 EST

ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.

PRPHProPhase Labs2026-06-25 13:46 EST

Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1

PRPHProPhase Labs2026-06-25 13:46 EST

ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories

PRPHProPhase Labs2026-06-25 13:46 EST

ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value

PRPHProPhase Labs2026-06-25 13:46 EST

ProPhase Labs Uplists from Pink Sheets to OTC Market

PRPHProPhase Labs2026-06-25 13:46 EST

ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture

PRPHProPhase Labs2026-06-25 13:46 EST

Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd

PRPHProPhase Labs2026-06-25 13:46 EST

ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative

PRPHProPhase Labs2026-06-25 13:46 EST

ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity

NRSNNeuroSense Therapeutics2026-06-25 13:46 EST

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

View all latest news

ProPhase Labs

ProPhase Labs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

Recent company news

PRPHProPhase Labs2026-06-26 10:02 EST

ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.

PRPHProPhase Labs2026-06-26 10:02 EST

Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1

PRPHProPhase Labs2026-06-26 10:02 EST

ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories

PRPHProPhase Labs2026-06-26 10:02 EST

ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value

PRPHProPhase Labs2026-06-26 10:02 EST

ProPhase Labs Uplists from Pink Sheets to OTC Market

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States